NZ701721A - Amides of 2-amino-4-arylthiazole compounds and their salts - Google Patents

Amides of 2-amino-4-arylthiazole compounds and their salts

Info

Publication number
NZ701721A
NZ701721A NZ701721A NZ70172113A NZ701721A NZ 701721 A NZ701721 A NZ 701721A NZ 701721 A NZ701721 A NZ 701721A NZ 70172113 A NZ70172113 A NZ 70172113A NZ 701721 A NZ701721 A NZ 701721A
Authority
NZ
New Zealand
Prior art keywords
salts
amides
amino
potassium salt
arylthiazole compounds
Prior art date
Application number
NZ701721A
Other languages
English (en)
Inventor
Suresh Mahadev Kadam
Abraham Thomas
Sukumar Sinha
Sukeerthi Kumar
Bipin Parsottam Kansagra
Sachin Gavhane
Sandeep Bandu Khandagale
Shailesh Pawase
Jayant Prakashrao Patil
Shailendra Bhadane
Bhavna Mishra
Rajesh Dwivedi
Original Assignee
Glenmark Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54193746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ701721(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glenmark Pharmaceuticals Sa filed Critical Glenmark Pharmaceuticals Sa
Publication of NZ701721A publication Critical patent/NZ701721A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NZ701721A 2012-06-08 2013-06-08 Amides of 2-amino-4-arylthiazole compounds and their salts NZ701721A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN1687MU2012 2012-06-08
US201261665282P 2012-06-27 2012-06-27
IN3519MU2012 2012-12-13
US201261748016P 2012-12-31 2012-12-31
PCT/IB2013/054703 WO2013183035A2 (en) 2012-06-08 2013-06-08 Amides of 2-amino-4-arylthiazole compounds and their salts

Publications (1)

Publication Number Publication Date
NZ701721A true NZ701721A (en) 2016-03-31

Family

ID=54193746

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ701721A NZ701721A (en) 2012-06-08 2013-06-08 Amides of 2-amino-4-arylthiazole compounds and their salts

Country Status (22)

Country Link
US (1) US9458173B2 (enExample)
EP (1) EP2858999B1 (enExample)
JP (1) JP5989900B2 (enExample)
KR (1) KR20150015488A (enExample)
CN (1) CN104350058A (enExample)
AP (1) AP3546A (enExample)
AU (1) AU2013273118B2 (enExample)
BR (1) BR112014029155A2 (enExample)
CA (1) CA2873570C (enExample)
CL (1) CL2014003317A1 (enExample)
EA (1) EA031334B1 (enExample)
HK (1) HK1207643A1 (enExample)
IL (1) IL236084A0 (enExample)
IN (1) IN2014MN02467A (enExample)
MX (1) MX354014B (enExample)
MY (1) MY165622A (enExample)
NZ (1) NZ701721A (enExample)
PE (1) PE20142306A1 (enExample)
PH (1) PH12014502685A1 (enExample)
SG (1) SG11201408093PA (enExample)
WO (1) WO2013183035A2 (enExample)
ZA (1) ZA201500082B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ724503A (en) 2012-06-08 2017-12-22 Gilead Sciences Inc Macrocyclic inhibitors of flaviviridae viruses
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
MX2015016024A (es) * 2013-06-20 2016-04-04 Glenmark Pharmaceuticals Sa Formulacion en nanoparticulas que comprende un antagonista para trpa1.
JP6573968B2 (ja) * 2014-08-11 2019-09-11 ハイドラ バイオサイエンシズ インコーポレイテッドＨｙｄｒａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． ＴＲＰＣ５調節因子としての、精神神経障害の処置のためのチエノおよびフロ［２，３−ｄ］ピリミジン−２，４［１Ｈ，３Ｈ］−ジオン誘導体
WO2016042501A1 (en) * 2014-09-16 2016-03-24 Glenmark Pharmaceuticals S.A. Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain
TW202321229A (zh) 2021-08-18 2023-06-01 美商富曼西公司 殺真菌的取代的雜環化合物
CN114671875A (zh) * 2022-04-27 2022-06-28 成都施贝康生物医药科技有限公司 新型二氢嘧啶类化合物、异构体或盐及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248231A1 (de) 1972-10-02 1974-04-11 Basf Ag 3-aminoisothiazolo eckige klammer auf 3,4-d eckige klammer zu pyrimidine
SE9701398D0 (sv) 1997-04-15 1997-04-15 Astra Pharma Prod Novel compounds
ES2193839B1 (es) * 2001-06-22 2005-02-16 Almirall Prodesfarma, S.A. Nuevos derivados de 6-fenildihidropirrolpirimidindiona.
AU2003253165A1 (en) 2002-08-13 2004-02-25 Warner-Lambert Company Llc Pyrimidine fused bicyclic metalloproteinase inhibitors
US6890923B2 (en) 2002-12-16 2005-05-10 Astrazeneca Ab Compounds
US7465581B2 (en) 2002-12-18 2008-12-16 The Scripps Research Institute ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons
CA2536313A1 (en) * 2003-08-22 2005-03-03 Takeda Pharmaceutical Company Limited Fused pyrimidine derivative and use thereof
US20070099940A1 (en) 2004-02-11 2007-05-03 Spearing Paul K Pth agonists
US20070196866A1 (en) 2004-03-13 2007-08-23 Irm Llc Modulators of ion channel trpa1
EP1847541A4 (en) 2005-02-03 2009-12-30 Takeda Pharmaceutical CONDENSED PYRIMIDINE DERIVATIVE AND USE THEREOF
US20070032531A1 (en) 2005-08-04 2007-02-08 Apogee Biotechnology Corporation Sphingosine kinase inhibitors and methods of their use
US20070105920A1 (en) 2005-11-08 2007-05-10 Akzo Nobel N.V. 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives
CN102499921A (zh) 2005-12-22 2012-06-20 海德拉生物科学公司 治疗疼痛的方法和组合物
CN101454318A (zh) * 2006-03-22 2009-06-10 阿斯利康(瑞典)有限公司 吡啶并嘧啶衍生物及其作为pde4抑制剂的用途
TW200800997A (en) 2006-03-22 2008-01-01 Astrazeneca Ab Chemical compounds
JP2011201776A (ja) 2008-07-23 2011-10-13 Mochida Pharmaceut Co Ltd ヘテロシクリデン−ｎ−（３，４−ジヒドロ−２（１ｈ）−キナゾリノン−５−イル）アセトアミド誘導体
CL2008000252A1 (es) 2007-01-29 2008-03-14 Xenon Pharmaceuticals Inc Compuestos derivados de quinazolinona o pirimidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades mediadas por los canales de calcio, tales como dolor, depresion, enfermedades cardiovasculares, respir
CA2691468C (en) 2007-06-22 2017-05-09 Hydra Biosciences, Inc. Substituted xanthine compounds and methods to treat diseases mediated by trpa1
US7951814B2 (en) * 2008-06-17 2011-05-31 Glenmark Pharmaceuticals, S.A. Quinazolinedione derivatives as TRPA1 modulators
WO2009158719A2 (en) 2008-06-27 2009-12-30 Hydra Biosciences, Inc. Methods and compositions for treating disorders
KR20110128898A (ko) 2009-03-23 2011-11-30 그렌마크 파머수티칼스 에스. 아. Ｔｒｐａ1 조절자로서 푸로피리미딘디온 유도체
AU2010227245B2 (en) 2009-03-23 2015-09-10 Glenmark Pharmaceuticals S.A. Fused pyrimidine-dione derivatives as TRPA1 modulators
US8623880B2 (en) 2009-03-23 2014-01-07 Glenmark Pharmaceuticals S.A. Fused pyrimidine-dione derivatives as TRPA1 modulators
ES2424340T3 (es) 2009-03-23 2013-10-01 Glenmark Pharmaceuticals S.A. Derivados de isotiazolo-pirimidindiona como moduladores de TRPA1
MY159059A (en) 2010-12-20 2016-12-15 Glenmark Pharmaceuticals Sa 2-amino-4-arylthiazole compounds as trpa1 antagonists

Also Published As

Publication number Publication date
AU2013273118A1 (en) 2014-11-27
JP5989900B2 (ja) 2016-09-07
IL236084A0 (en) 2015-02-01
MY165622A (en) 2018-04-18
EP2858999A2 (en) 2015-04-15
EP2858999B1 (en) 2017-05-10
PH12014502685B1 (en) 2015-01-26
US20150111038A1 (en) 2015-04-23
CL2014003317A1 (es) 2015-02-13
AP3546A (en) 2016-01-14
WO2013183035A3 (en) 2014-02-27
AP2014008076A0 (en) 2014-11-30
CA2873570C (en) 2016-11-01
BR112014029155A2 (pt) 2017-06-27
PE20142306A1 (es) 2015-01-16
MX2014014482A (es) 2015-06-05
KR20150015488A (ko) 2015-02-10
SG11201408093PA (en) 2015-01-29
EA201492054A1 (ru) 2016-08-31
AU2013273118B2 (en) 2015-11-05
HK1207643A1 (en) 2016-02-05
MX354014B (es) 2018-02-08
ZA201500082B (en) 2015-12-23
CA2873570A1 (en) 2013-12-12
US9458173B2 (en) 2016-10-04
WO2013183035A2 (en) 2013-12-12
CN104350058A (zh) 2015-02-11
EA031334B1 (ru) 2018-12-28
JP2015520183A (ja) 2015-07-16
IN2014MN02467A (enExample) 2015-07-10
PH12014502685A1 (en) 2015-01-26

Similar Documents

Publication Publication Date Title
NZ701721A (en) Amides of 2-amino-4-arylthiazole compounds and their salts
EA201391239A1 (ru) Пирроло[2,3-d]пиримидиновые производные в качестве ингибиторов тропомиозин-связанных киназ
MD20140072A2 (ro) Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin
PE20130188A1 (es) Pirrolidinonas heteroaromaticas fusionadas como inhibidores de syk
MY160785A (en) Manufacturing process for pyrimidine derivatives
HK1202541A1 (en) 2-amino, 6-phenyl substituted pyrido [2, 3 - d] pyrimidine derivatives useful as raf kinase inhibitors
WO2014128545A3 (en) An improved process for the preparation of dolutegravir
MD4490B1 (ro) Noi compuşi de indolizină, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin
NZ749557A (en) 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1h)-one derivatives as fungicides
WO2010091808A8 (en) Fused pyrimidines
PH12018501643A1 (en) Tlr7 agonist crystalline form a, preparation method and use thereof
PH12015502409A1 (en) Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists
MX2015013745A (es) Preparacion de intermediarios de pirimidina utiles para la preparacion de maci tentano.
PH12014502210A1 (en) Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one
MX360001B (es) Compuestos de acrilamida como ligandos receptores de histamina h3.
NZ705994A (en) Process for preparing pemetrexed di potassium and its hydrates
TH155635A (th) เอไมด์ของสารประกอบ 2-อะมิโน-4-เอริลไธอะโซลและเกลือของสารประกอบดังกล่าว
TN2013000094A1 (en) Manufacturing process for pyrimidine derivatives
TH149193A (th) สารประกอบไพราโซโลไพริมิดีน และการใช้พวกมันในฐานะเป็นตัวยับยั้ง pde 10
TH90536B (th) สารประกอบยูราซิล และสารฆ่าวัชพืช ซึ่งประกอบรวมด้วยสารเดียวกันนี้
GB2527958A (en) Pregnane-oximino-aminoalkylethers and process for preparation thereof, useful as antidiabetic and antidyslipidemic agents
WO2014165633A8 (en) Cycloalkyl-dione derivatives and methods of their use
IN2013CH05870A (enExample)
AU2011355362A8 (en) 5-([1,2,3]Triazole-4-yl)-7H-pyrrolo[2,3-d]pyrimidine derivatives
TH149193B (th) สารประกอบไพราโซโลไพริมิดีน และการใช้พวกมันในฐานะเป็นตัวยับยั้ง pde 10

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed